Vor Biopharma Inc. Share Price & Technical Analysis
VOR · $14.33 (-4.72%)
Healthcare / Biotechnology
$14.33
-4.72%
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with Rem…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -28% avg return in past 3 year May month.
14% return in 2026, 148% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | 20% | 19% | -23% | 0% | – | – | – | – | – | – | – | 14% |
| 25 | 27% | -22% | -32% | -4% | -71% | 710% | 34% | -2% | 22% | -49% | -66% | 58% | 606% |
| 24 | 2% | -1% | 0% | -29% | -19% | -26% | -10% | -10% | -21% | 14% | 0% | 31% | -70% |
| 23 | -21% | 4% | -4% | -16% | 7% | -35% | -4% | -17% | -15% | -13% | 1% | 21% | -92% |
| 22 | -29% | 9% | -33% | -6% | -26% | 23% | -11% | 11% | -21% | 18% | -5% | 39% | -31% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$841.50M
P/E ratio
—
52W high
$65.80
52W low
$3.30
Volume
7,28,620
Beta
1.75
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Vor Biopharma Inc. share price today?
- Vor Biopharma Inc. (VOR) last traded around $14.33 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does VOR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for VOR. Download the app for real-time alerts.
- How can I analyze Vor Biopharma Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.